ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
On August 16, 2019, Ai Lingyu, director of Shanxi Investment Promotion Bureau, and his party visited our company for inspection.
Ai Lingyu, director of Shanxi Investment Promotion Bureau, listened to the company's introduction.
Ai Lingyu, director of Shanxi Investment Promotion Bureau, and his party visited the PP infusion workshop.